ipo

Aprameya Engineering IPO

Incorporated in September 2003, Aprameya Engineering Limited installs and maintains Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards in hospitals and medical care centres. They provide these services on a turnkey basis and also supply high-value healthcare and diagnostic equipment to private hospitals, government hospitals, and medical practitioners.

Issue Open
25-07-2024
Issue Close
29-07-2024
Allotment Date
30-07-2024
Listing Date
01-08-2024
IPO Details
Issue Open 25-07-2024
Issue Close 29-07-2024
Allotment Date 30-07-2024
Listing Date 01-08-2024
IPO Price Band ₹56 to ₹58
Minimum Share Bid 2000
Minimum Investment Amount ₹116000
Total Issue Size 50,40,000 shares (up to ₹29.232 Cr)
Fresh Issue 50,40,000 shares (up to ₹29.232 Cr)
Offer For Sale -
Face Value ₹10 Per Share
Employee Discount -
Qualified Institutional Buyer [QIB] 50%
High Networth Individual [HNI] 15%
Retail Individual Investor [RII] 35%
Listed on NSE SME
Listing Details
Listing Date 01-08-2024
BSE Code -
NSE Code APRAMEYA
ISIN Code INE0LQG01010
IPO Price ₹ 58
Lot Size 2000
Expected Listing Price ₹ 70 to ₹ 80
Book Profit ₹ 90
Stop Loss ₹ 60

Can't fetch the data

Company Financials
Financial YearTotal AssetTotal RevenueTotal ExpensesProfit
FY-202110.8726.0124.461.02
FY-202248.7200.26176.1316.61
FY-202361.8978.3370.855.36
30-09-2023----
Valuation
Earnings Per Share [EPS] ₹ 2.47
Price/Earnings [P/E] Ratio 23.49
Return on Net Worth [RoNW] 14.79 %
Net Asset Value [NAV] -
Lot Size
ApplicationLot SizeSharesTotal Amount
Retail Min12,000₹ 1,16,000
Retail Max12,000₹ 1,16,000
Small HNI24,000₹ 2,32,000
Important Disclaimer
LiveIPO Logo Download the LiveIPO App from Google Play Store

The content provided in this application is for educational and informational purposes only. It does not constitute financial advice to buy or sell securities, invest in IPOs, or make any other financial decisions. All information reflects data and market perceptions as of the publication date. We are not SEBI-registered analysts. Please consult a qualified financial advisor before making investment decisions. By using this app, you agree to our terms and conditions.

© 2024 LiveIPO. All rights reserved.